臨床試驗

Suprachoroidal Administration in Subjects With Metastases to the Choroid

NCT：NCT06643884 · RECRUITING

NCT IDNCT06643884

狀態RECRUITING

開始日期2024-12-16

完成時間2027-10-31

SponsorAura Biosciences (INDUSTRY)

First posted2024-10-16

Last updated2026-10-08

簡要摘要

The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。